Literature DB >> 10749660

Regulation of cytochrome P450 (CYP) genes by nuclear receptors.

P Honkakoski1, M Negishi.   

Abstract

Members of the nuclear-receptor superfamily mediate crucial physiological functions by regulating the synthesis of their target genes. Nuclear receptors are usually activated by ligand binding. Cytochrome P450 (CYP) isoforms often catalyse both formation and degradation of these ligands. CYPs also metabolize many exogenous compounds, some of which may act as activators of nuclear receptors and disruptors of endocrine and cellular homoeostasis. This review summarizes recent findings that indicate that major classes of CYP genes are selectively regulated by certain ligand-activated nuclear receptors, thus creating tightly controlled networks.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749660      PMCID: PMC1220963          DOI: 10.1042/0264-6021:3470321

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  298 in total

1.  Transcriptional regulatory elements for basal expression of cytochrome P450IIC genes.

Authors:  P Venepally; D Chen; B Kemper
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

2.  Purification and characterization of a transcription factor which appears to regulate cAMP responsiveness of the human CYP21B gene.

Authors:  N Kagawa; M R Waterman
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

3.  A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s.

Authors:  K Morohashi; S Honda; Y Inomata; H Handa; T Omura
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

4.  Steroidogenic factor 1, an orphan nuclear receptor, regulates the expression of the rat aromatase gene in gonadal tissues.

Authors:  J P Lynch; D S Lala; J J Peluso; W Luo; K L Parker; B A White
Journal:  Mol Endocrinol       Date:  1993-06

Review 5.  Olfaction in humans with special reference to odorous 16-androstenes: their occurrence, perception and possible social, psychological and sexual impact.

Authors:  D B Gower; B A Ruparelia
Journal:  J Endocrinol       Date:  1993-05       Impact factor: 4.286

Review 6.  P450 enzymes of estrogen metabolism.

Authors:  C P Martucci; J Fishman
Journal:  Pharmacol Ther       Date:  1993 Feb-Mar       Impact factor: 12.310

7.  The lithocholic acid 6 beta-hydroxylase cytochrome P-450, CYP 3A10, is an active catalyst of steroid-hormone 6 beta-hydroxylation.

Authors:  T K Chang; J Teixeira; G Gil; D J Waxman
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

8.  Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily.

Authors:  S Honda; K Morohashi; M Nomura; H Takeya; M Kitajima; T Omura
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

9.  The orphan nuclear receptor NGFI-B regulates expression of the gene encoding steroid 21-hydroxylase.

Authors:  T E Wilson; A R Mouw; C A Weaver; J Milbrandt; K L Parker
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

10.  Regulation of the mouse liver cytochrome P450 2B subfamily by sex hormones and phenobarbital.

Authors:  P Honkakoski; A Kojo; M A Lang
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

View more
  78 in total

1.  Adrenomedullin2 (ADM2)/intermedin (IMD) in rat ovary: changes in estrous cycle and pregnancy and its role in ovulation and steroidogenesis.

Authors:  Madhu Chauhan; Meena Balakrishnan; Chellakkan S Blesson; Chandra Yallampalli
Journal:  Biol Reprod       Date:  2014-11-13       Impact factor: 4.285

Review 2.  Antiepileptic-induced resistance to neuromuscular blockers: mechanisms and clinical significance.

Authors:  Sulpicio G Soriano; J A Jeevendra Martyn
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Availability of specific reductases controls the temporal activity of the cytochrome P450 complement of Streptomyces coelicolor A3(2).

Authors:  Li Lei; Michael R Waterman; Armand J Fulco; Steven L Kelly; David C Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

4.  Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice.

Authors:  Young Joo Park; Eun Kyung Lee; Yoon Kwang Lee; Do Joon Park; Hak Chul Jang; David D Moore
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-03       Impact factor: 4.219

Review 5.  P450 monooxygenases (P450ome) of the model white rot fungus Phanerochaete chrysosporium.

Authors:  Khajamohiddin Syed; Jagjit S Yadav
Journal:  Crit Rev Microbiol       Date:  2012-05-25       Impact factor: 7.624

Review 6.  Vaccine-Drug Interactions: Cytokines, Cytochromes, and Molecular Mechanisms.

Authors:  Paolo Pellegrino; Cristiana Perrotta; Emilio Clementi; Sonia Radice
Journal:  Drug Saf       Date:  2015-09       Impact factor: 5.606

Review 7.  [Effect of intestinal cytochrome P450 3A on phytochemical presystemic metabolism].

Authors:  Fang Xia; Xiao-yin Chen
Journal:  Chin J Integr Med       Date:  2005-09       Impact factor: 1.978

8.  Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension.

Authors:  V R Holla; F Adas; J D Imig; X Zhao; E Price; N Olsen; W J Kovacs; M A Magnuson; D S Keeney; M D Breyer; J R Falck; M R Waterman; J H Capdevila
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 9.  Diet, fatty acids, and regulation of genes important for heart disease.

Authors:  John P Vanden Heuvel
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

10.  Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity.

Authors:  Yuzhi Jia; Grace L Guo; Sailesh Surapureddi; Joy Sarkar; Chao Qi; Dongsheng Guo; Jun Xia; Papreddy Kashireddi; Songtao Yu; Young-Wook Cho; M Sambasiva Rao; Byron Kemper; Kai Ge; Frank J Gonzalez; Janardan K Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.